Published in Cancer Weekly, April 3rd, 2012
"All cases were assessed for disease-specific survival as well as local control rates, with respect to T and N classification, status of surgical margins, decision on neck management, and adjuvant therapy. Cases...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.